Drug Trial Radar · NCT06226805
Study of BB-031 in Acute Ischemic Stroke Patients (RAISE)
Last checked: Nov 19, 2026Latest source record: Oct 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
228
Planned (sponsor's estimate)
Start
Jul 31, 2024
Primary completion
Jun 2027
Study completion Sep 2027
Sponsor
- Lead sponsor
- Basking Biosciences, Inc.Industry
- Sponsor type
- Industry
- First posted
- Jan 26, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Prevention
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the safety and tolerability of ascending doses (Part A) and selected doses (Part B) of BB-031 in acute ischemic stroke patients presenting within 24 hours of stroke onset. Participants will be randomized to receive one dose of either the investigational drug or placebo and will be followed for 90 days. A total of 228 patients are planned in this study.
Conditions
- Acute Ischemic Stroke
Interventions
BB-031Drug
Solution for injection
PlaceboDrug
0.9% sodium chloride for injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- Symptomatic Intracranial Hemorrhage (sICH)Time frame: 24 hours
Locations
25 sites in 3 countries. Site status is shown where the registry gives one.
HonorHealth Bob Bove Neuroscience Institute
Scottsdale, Arizona · Recruiting
Mills Peninsula Medical Center
Burlingame, California · Withdrawn
MemorialCare Long Beach Medical Center
Long Beach, California · Withdrawn
California Pacific Medical Center
San Francisco, California · Withdrawn
Pacific Neurosciences Institute at Saint John's Physician Partners
Torrance, California · Recruiting
Baptist Health Medical Center
Jacksonville, Florida · Terminated
Henry Ford Hospital
Detroit, Michigan · Recruiting
Washington University in St. Louis
St Louis, Missouri · Recruiting
Cooper University Hospital
Camden, New Jersey · Recruiting
WakeMed
Raleigh, North Carolina · Recruiting
The Ohio State University
Columbus, Ohio · Recruiting
ProMedica Toledo Hospital
Toledo, Ohio · Recruiting
Mercy Health St. Vincent Medical Center
Toledo, Ohio · Recruiting
Valley Baptist Medical Center - Harlingen
Harlingen, Texas · Recruiting
Memorial Hermann Hospital
Houston, Texas · Terminated
John Hunter Hospital
New Lambton Heights, New South Wales, Australia · Recruiting
Princess Alexandra Hospital
Woolloongabba, Queensland, Australia · Recruiting
Royal Adelaide Hospital
Adelaide, South Australia, Australia · Recruiting
Monash Medical Centre
Clayton, Victoria, Australia · Terminated
The Royal Melbourne Hospital
Parkville, Victoria, Australia · Recruiting
Fiona Stanley Hospital
Murdoch, Western Australia, Australia · Recruiting
University of Calgary
Calgary, Alberta, Canada · Recruiting
University of Alberta Hospital
Edmonton, Alberta, Canada · Recruiting
Vancouver Stroke Program
Vancouver, British Columbia, Canada · Recruiting
Ottawa Hospital Research Institute
Ottawa, Ontario, Canada · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.